Updated hourlyHourly refreshWed, Oct 28, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare · Biotech & pharma
HBC recorded total operating revenues of NOK 65.7 million in the second quarter of 2026, compared to NOK 68.4 million in the same period last year. Net operating revenues were NOK 63.1 million, down from NOK 67.8 million in Q2 2025. EBITDA for the quarter was negative NOK 2.7 million, compared to negative NOK 5.4 million in Q2 2025. The Operational EBITDA* amounted to negative NOK 0.6 million (positive NOK 1.3 million in Q2 2025), excluding non-recurring and strategic development costs such as clinical trials and R&D expenses, and Berkåk project costs. The operating result (EBIT) was negative NOK 12.9 (-14.9) in the last quarter. Cash and cash equivalents increased by NOK 59.7 million during the quarter, ending at NOK 108.0 million as of 30 June 2026 (68.0). Including available credit facilities, total liquidity was NOK 109.0 million at quarter-end (76.5).
Aug 21 · 06:15·GlobeNewswire
Healthcare · Biotech & pharma
HONG KONG, Aug. 21, 2026 -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its investigational next-generation B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received clinical trial clearance from the Center for Drug Evaluation (CDE) of...
Aug 21 · 05:30·PR Newswire
Healthcare · Food & drink
VADUZ, Liechtenstein, Aug. 21, 2026 -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announced today that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for RefluxStop®, the...
Aug 21 · 03:36·PR Newswire
Healthcare · Cybersecurity
Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the Nebraska Orthopaedic Center data breach.
Aug 21 · 02:53·GlobeNewswire
Finance · SaaS
ATLANTA, Aug. 20, 2026 -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, announced today the pricing of the previously announced secondary offering by certain selling stockholders (the “Selling Stockholders”), including affiliates of J.H. Whitney Equity Partners VII, LLC and certain current and former directors and officers of the Company, of 15,000,000 shares of its common stock at a price of $11.75 per share (the “Offering”). Certain affiliates of J.H. Whitney Equity Partners VII, LLC have also granted the underwriter a 30-day option to purchase up to an additional 2,250,000 shares of the Company’s common stock. The Selling Stockholders will receive all of the net proceeds from the Offering. The Company is not offering any shares of its common stock in the Offering and will not receive any of the proceeds from the sale of the shares offered by the Selling Stockholders. The Offering is expected to settle on August 24, 2026, subject to customary closing conditions.
Aug 21 · 00:16·GlobeNewswire
Healthcare · Biotech & pharma
Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCC Strong Cash Position Supports Continued Strategic Execution...
Aug 20 · 23:10·PR Newswire
Healthcare
Rebrand reflects expanded behavioral health services alongside continued substance misuse prevention, intervention, treatment and recovery programs; ribbon cutting set for August 21 in Rock Hill, S.C.
Rebrand reflects expanded behavioral health services alongside continued substance misuse prevention, intervention, treatment and recovery programs; ribbon cutting set for August 21 in Rock Hill, S.C.
Aug 20 · 23:09·GlobeNewswire
Healthcare
Vancouver, British Columbia--(August 20, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") is pleased to announce its intention to complete a non-brokered private placement of convertible debentures of the Company (the "Debentures") in an aggregate principal amount of up to $500,000, issuable in increments of $1,000 principal amount, for aggregate gross proceeds of up to $500,000 (the "Offering"). The Offering is expected...
Aug 20 · 22:14·Newsfile
Healthcare
Major milestone reinforces commitment to restoring essential inpatient care close to home for Unicoi County residents
Major milestone reinforces commitment to restoring essential inpatient care close to home for Unicoi County residents
Aug 20 · 21:21·GlobeNewswire
Healthcare · Biotech & pharma
First Alzheimer's blood test cleared for patients as young as 40, advancing the ADDF's long-standing push to close the gap between early pathology and early detection Milestone reflects nearly two decades of sustained ADDF investment, expanding access to scalable blood-based diagnostics...
Aug 20 · 21:01·PR Newswire
AI · Healthcare
Results characterized by continued strong commercial momentum and improved operating performance Conference call/webcast today at 5:00 pm ET TORONTO and DALLAS, Aug. 20, 2026 -- Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a...
Aug 20 · 20:30·PR Newswire
SaaS · Healthcare
3,633 physician licenses were issued in a single month through the Interstate Medical Licensure Compact — American Medical Association, 2026. SCOTTSDALE, Ariz., Aug. 20, 2026 -- Promise, a Scottsdale-based telehealth platform offering doctor-guided consultations for peptide...
Aug 20 · 18:12·PR Newswire